tDCS Current Evidence in Neurology and Home-Based Applications (2025)
Transcranial direct current stimulation in MS, Parkinson, stroke rehabilitation, and home-based protocols.
tDCS: Current Evidence (2024-2025)
Transcranial direct current stimulation (tDCS) modulates cortical excitability by applying low-intensity direct current (1-2 mA) through the scalp. Distinguished by low cost, ease of application, and home-based use potential.
MS Fatigue (Strongest Evidence)
- Charvet et al. (Neurology, 2024): Home-based remotely supervised tDCS — significant MFIS reduction
- Evidence level: Level B
Parkinson's Disease
Motor cortex anodal tDCS for gait improvement, DLPFC for cognitive function. Level C evidence.
Stroke Rehabilitation
Motor recovery, aphasia, hemineglect. STARS trial (Lancet Neurol, 2024) showed benefit of tDCS + robot therapy combination. Level B evidence for motor rehabilitation.
Pain Management
Level B evidence for chronic pain and fibromyalgia. Motor cortex or DLPFC stimulation.
Home-Based Applications
The biggest advantage of tDCS. Remotely supervised protocols with video conferencing, smart headcaps with predetermined montages, and automatic safety controls.